Chromatin loops form a basic unit of interphase nuclear organisation, providing contacts between regulatory regions and target promoters, and forming higher level patterns defining self interacting domains. Recent studies have shown that mutations predicted to alter chromatin loops and domains are frequently observed in tumours and can result in the upregulation of oncogenes, but the combinations of selection and mutational bias underlying these observations remains unknown. Here, we explore the unusual mutational landscape associated with chromatin loop anchor points (LAPs), which are located at the base of chromatin loops and form a kinetic trap for cohesin.
INTRODUCTION
. Hnisz et al. (2016) have shown that constitutive CTCF-CTCF binding site interactions delineating loops are recurrently deleted in T-cell acute lymphoblastic leukemia, leading to oncogene activation. Overall, these data suggest that domain boundary or LAP lesions affecting gene regulation are far from rare in cancers, occurring at comparable rates to recurrent in-frame gene fusions (Weischenfeldt et al. 2017 ). However, it is unclear whether LAPs are intrinsically prone to high mutation rates in cancer, constituting a novel class of fragile sites in the genome, or whether the observed lesions affecting LAPs confer a selective advantage to tumour cells.
Somatic mutation rates vary across the genome, and a large fraction of this variation can be attributed to differences in replication timing, with late replicating regions of the genome accumulating increased levels of single nucleotide variants (SNVs) (Stamatoyannopoulos et al. 2009 ). Large regions of chromosomes (encompassing hundreds of Kb) are replicated synchronously in replication domains that correspond closely to TADs, linking chromatin organisation to spatiotemporal variation in replication (Dileep et al. 2015) , while other, inter-correlated features of chromatin, such as histone methylation or acetylation patterns, are also associated with somatic mutation rates (Schuster-Bockler and Lehner 2012). On a much finer scale, the individual binding sites of a variety of DNA binding factors, including CTCF, appear to obstruct the lagging strand replication and DNA repair machinery and induce higher mutation rates in human and yeast (Reijns et al. 2015; Perera et al. 2016; Sabarinathan et al. 2016) . However the mutational landscape associated with intermediate levels of chromatin organisation, such as chromatin loops, are not well studied.
During meiosis, recombination is initiated by double-strand breaks (DSBs) and occurs non-randomly across genomes; it is at its highest level at recombination hotspots (HSs) where the majority (60%) of recombination events take place Coop et al. 2008) . While it is known that recombination produces large structural variants, the effect of recombination on the emergence of single nucleotide variants is less clear -as is its relation to chromatin structure. There is evidence that recombination is mutagenic in yeast (Strathern et al. 1995; Hicks et al. 2010) , and a recent study of 283 human trios has shown a correlation between the rate of recombination events in parental germ cell genomes and the rate of de novo SNVs in offspring genomes, suggesting a mutagenic effect of HSs (Besenbacher et al. 2016 ).
However, the data supporting this were necessarily sparse, given the low de novo mutation rates in the normal human genome. Replication and recombination associated mechanisms are also hypothesised to lead to the formation of structural variants during mitosis, and may therefore contribute to structural variation in cancers (Carvalho and Lupski 2016) . The influence of genomic features on structural rearrangements in cancer is relatively under-studied, but it seems that different cancer types follow different patterns. For some cancer types, such as breast cancer, structural somatic variants are enriched within early replicating, GC rich, transcribed regions of the genome (Drier et al. 2013) , whereas the opposite trend was observed for cancers such as prostate and melanoma.
Here, we explore the unusual mutational landscape of LAPs, discovering significant depletions of SNVs at LAPs across multiple tumour types. Using matched replication timing and chromatin data, we find that these depletions can be explained by the mutational biases associated with LAPs. Paradoxically, we show that LAPs are also associated with increased rates of SVs in tumours and often overlap somatic DSB hotspots and meiotic recombination HSs. Like canonical common fragile sites, we find that LAPs are bound by components of DNA repair complexes such as BRCA1 and RAD51, and that BRCA-deficient tumours show different SNV rates at LAPs compared to wildtype tumours. LAPs which overlap recombination HSs are associated with increases in single nucleotide polymorphism (SNP) rates in extant human populations, suggesting that particular classes of LAPs act as reservoirs of sequence variation for evolution in the recent human lineage. We conclude that the unusual chromatin environment at LAPs influences the mutation rates observed and causes LAPs to be foci of evolutionary change.
RESULTS

Previous work has demonstrated elevated SNV rates at CTCF binding sites within
LAPs in a variety of cancers (Kaiser et al. 2016) . This motivated us to investigate genome-wide somatic mutation rates around high confidence LAPs from the aggregated Hi-C datasets (see Methods) of Rao et al. (2014) , using 13 recently released ICGC somatic variant datasets ascertaining both SNVs and SVs in 9 different tumour types (International Cancer Genome et al. 2010) . The ICGC pan-cancer SNV rates show a dramatic drop within 50 Kb of LAPs ( Figure 1A ). This regional decrease in SNVs at LAPs is in stark contrast to the high mutation rate observed at the short 19bp binding CTCF-motifs located inside LAPs of 12.3 SNVs/Mb -1 , or >3 times higher than the local background mutation rate. Plotting SNV rates at 20bp resolution, a peak of SNVs in the centre of the LAPs at CTCF binding sites becomes apparent (as seen in Kaiser et al. (2016) ), as well as a periodic pattern of mutation reflecting nucleosome occupancy ( Figure 1B ) observed previously in breast tumour data (Morganella et al. 2016) . Thus, CTCF binding sites within LAPs are prone to local somatic hypermutation in tumours, but, unexpectedly, these sites often reside within broader genomic regions with significantly reduced SNV rates. 
Chromatin loop anchors are hotspots of structural variation in tumours and recombination in human populations
In contrast to SNVs, the frequency of pan-cancer SV breakpoints shows a significant increase at LAPs, inverting the pattern seen for SNVs over the same range of flanking sequence ( Figure 1C ). This implies that LAPs are structurally fragile sites in cancer, and so we examined associations between LAPs and more direct measures of genomic instability. Lensing et al. (2016) identified genome-wide foci of endogenous DSBs in vitro, and these sites show a striking ~3.7-fold enrichment at LAPs ( Figure   2A ). A proportion of this enrichment may be attributable to the close proximity of LAPs to promoters and enhancers, which are known to suffer elevated DSB rates (Lensing et al. 2016 ). However, LAPs lacking any overlap with known promoters and enhancers show similarly elevated rates to those that do (Supplemental Figure S1 ).
Consistent with this, LAPs are also enriched in predicted G-quadruplexes (G4s), a DNA secondary structure associated with regulatory regions and DSB formation in cancers (Hänsel-Hertsch et al. 2017) ( Figure 2B ). To our knowledge this is the first demonstration that LAPs are sites of inherent genomic instability, associated with an accumulation of SVs in their vicinity in tumour cells (Gaillard et al. 2015) .
Intriguingly, LAPs also show an unexpected genome-wide correspondence with germline recombination HSs, calculated from genotyping of extant human populations (The 1000 Genomes Project Consortium et al. 2015) , such that 16% of LAPs overlap HSs (p < 10 -5 ; Figure 2C ). These overlaps are notably precise, so that the association between LAPs and HSs drops when the two sets of regions are shifted with respect to each other by less than 50 Kb ( Figure 2D ). Thus, this correspondence is not simply attributable to the enrichment of both sets of features within certain broader neighbourhoods such as replication timing domains or nuclear compartments.
Recombination HSs are known to often contain the motif bound by PRDM9, a critical component of the recombination machinery (Myers et al. 2010; Pratto et al. 2014) , and, using stringent search criteria (see Methods), we find this motif in 17% of HSs.
Similarly, we find that 13% of LAPs also contain at least one PRDM9 core motif, which is an enrichment of ~33% compared to the median number of motifs per 5 Kb bin in LAP flanking regions ( Figure 2E ). For the 16% of LAPs directly overlapping HSs (HS-LAPs) there is a notable increase in the recombination rate measured at those LAPs, but, beyond these HS-LAPs, there is no evidence for increased levels of recombination at LAPs in the germline ( Figure 2F ). This is consistent with dual roles for a subset of LAPs, both as units of chromatin organisation and as hotspots of structural variation. Although PRDM9 is normally expressed exclusively in testis, it is also expressed in a variety of cancer cell lines and samples, and has been proposed as a cancer biomarker (Feichtinger et al. 2012 ). We observe modestly increased SNV rates at recombination HSs in cancer, but do not find any pan-cancer increase in SV breakpoints around HSs (Supplemental Figure S2 ), which might be expected if meiotic recombination complexes were activated in the tumours examined here. In addition, the histone modification H3K4me3, which is deposited by PRDM9 at DSBs, is not observed at recombination HSs in the HepG2 cell line (Supplemental Figure   S3 ) nor in MCF-7 (data not shown Figure S3 ). We cannot, however, exclude the possibility that PRDM9 is active in at least a subset of the tumours under investigation, and is responsible for the increase in SV rates at LAPs.
A substantial fraction of LAPs (47% of those studied here) constitute regulatory domain boundaries (Rao et al. 2014) , while an even higher proportion, 69%, overlap DSB-foci (Lensing et al. 2016) , and 16% overlap recombination HSs (Table 1) . However, genome-wide, these three categories of LAPs appear to be largely independent, as the extent of overlap between categories was remarkably similar to the expected rate assuming independent distributions across the genome.
For example, LAPs that appear as domain boundaries were as likely to overlap recombination HSs as LAPs that do not act as boundaries (Table 1) . Furthermore, there was no enrichment of GO terms associated with the genes neighbouring HS- Although the three categories of LAPs (those annotated as domain boundaries, DSB regions and recombination HSs) occur to a large degree at distinct locations, they are associated with similar mutational landscapes in tumours. All three categories show the distinctive dip in SNV rates at LAPs ( Figure 3A) , while cancer mutation rates somewhat increase around recombination HSs, by ~3.5% compared to the median rate within the flanking regions. As expected, recombination HSs are associated with a pronounced increase in SNPs in the 1KG dataset, and LAPs that overlap HSs are also enriched for segregating variants in the 1KG dataset, by ~7% compared to the flanking regions ( Figure 3B ). Accordingly, population genetic processes that increase variation at HSs -such as selective sweeps and reductions in background selection (Charlesworth 2009 ) -also appear to have impacted germline variation at HS-LAPs. However, germline de novo SNV rates at LAPs are not reduced as they are in cancer and, similarly, we do not observe an increase in SVs near HSs (Supplemental Figure S2 ), suggesting fundamentally different influences on germline mutation rates versus cancer associated somatic mutation rates at these sites. Figure S3 ).
Recombination HSs also show locally increased GC content, but otherwise generally possess a contrasting set of features, consistent with their presence in later replicating regions (Supplemental Figure S3 ). Accordingly, LAPs tend to be enriched for genes and actively transcribed regions (Rao et al. 2014) , whereas HSs are located, on average, further away from genic sequence. This raises the possibility that the unusual mutational properties of LAPs may be explained by their distinctive chromatin and sequence features.
We used random forest regression models to assess the extent to which mammary epithelium derived chromatin features (from the MCF-7 and MCF10A cell lines) and a variety of other features were associated with mutation rates in a large ICGC breast tumour dataset (BRCA-EU). Specifically, we constructed models of mutation rates observed within all 5 Kb windows from the 500 Kb regions flanking all mammary epithelium LAPs (derived from HMEC cell line Hi-C data) plus the 5
Kb LAP regions themselves (Methods). Similar models have previously shown high predictive accuracy in modelling aspects of nuclear organisation and provide variable importance estimates that are robust to the inter-correlated nature of chromatin feature input variables (Moore et al. 2015) . In our model, by far the most important predictor of the BRCA-EU SNV rate was replication timing, with reduced levels of mutation observed in early replicating regions (Figure 4) , consistent with other studies of breast cancer mutation patterns (Morganella et al. 2016) . Notably, the allocation of a genomic region to a LAP had little impact on the SNV rate, i.e. changes in mutation rates were mostly explained by the genomic features at LAPs, rather than by LAP presence. The correlation coefficient between observed and predicted SNV rates from the random forest model (r = 0.28; p-value < 10 -15 ) suggests a significant influence of the features included but, overall, a moderate level of predictive accuracy. Modelling was less successful in predicting BRCA-EU SV breakpoint rates (r = 0.09 between observed and predicted values) but also indicated a significant association with chromatin and sequence features (p-value < 10 -15 ), most notably BRCA1 ( Figure 4B ).
However, the effects of most features on mutation rates are strikingly inverted for SNV and SV rates, such that the variables most strongly correlated with elevated SV rates (DNaseHS, replication timing, G-quadruplex content, GC content) are associated with decreased SNV rates ( Figure 4C ). We conclude that similar chromatin and sequence features have significant, but largely opposing, effects upon SNV and SV rates at LAPs.
The modest overall predictive power of the SNV and SV random forest models undoubtedly reflects the necessarily incomplete nature of the chromatin and sequence features included as input, omitting many currently unavailable variables.
Additional limitations are expected to result from the current sample sizes of variant datasets, limiting the resolution of the modelling to 5 Kb regions that are much larger than many of the chromatin and sequence features. In support of this, smaller subregions within HMEC LAPs annotated as insulator, promoter or enhancer sites in HMEC cells (see Methods) differ significantly in their mutation rates and replication (Table S2 ). Beyond differences in SNV dataset sample sizes, this variability among tumour types may reflect the limitations of the current Hi-C data, which may be poorly matched to the cells in certain cancer samples. In addition, SVs are, on average, ~100-fold less frequent than SNVs ( Supplemental Table S2 ), and stratifying SVs by tumour type reduces the power to detect any patterns on a per-tumour basis.
BRCA1/2 deficient breast tumours suffer higher mutation loads at LAPs
BRCA1 and BRCA2 are well-characterised tumour suppressor genes involved in DSB repair by homologous recombination (Deng and Wang 2003; Lord and Ashworth 2012; Walsh 2015) . BRCA1 is often recruited to sites of active transcription, which are prone to DNA damage during the formation of transcriptional R-loops (Hatchi et al. 2015) . We found a strong enrichment of BRCA1 at HMEC LAPs (but not HSs) in MCF10A, a normal breast epithelial cell line, as well as increased RAD51 binding (which mediates BRCA2 binding) around LAPs in the MCF-7 cell line ( Figure 5 ). BRCA1-binding at LAPs in MCF10A cells was a relatively influential predictor in the random forest SV model (above), such that higher levels of BRCA1 binding was associated with higher SV rates (Figure 4) . To our knowledge, this is the first observation of BRCA1/2 association with LAPs, and with mutation rates at LAPs. To further investigate the importance of BRCA1/BRCA2 binding at LAPs, we exploited a recent classification of BRCA-EU breast cancer tumours as BRCA1/BRCA2 deficient (Davies et al. 2017 ).
BRCA1/BRCA2 deficient samples have higher genome-wide SNV rates, but a less pronounced dip in mutation rates around HMEC LAPs compared with BRCA wildtype tumours ( Figure 5 ). In the BRCA deficient samples, Figure 5E and 5F ). We conclude that deficiencies in BRCA1/BRCA2 are associated with an increase of SNVs at LAPs (reflected in a less pronounced dip in SNV rate) and a general increase in SV generation that is not confined to LAPs.
These (BRCA-EU) breast tumours show a strong C>G and C>T signature at TpCpN sites which is less pronounced for BRCA1-BRCA2 deficient tumours (Supplemental Figure S6A ), as expected since the classification of these tumours was largely based upon SNV mutation signatures (Davies et al. 2017) . While most of the variation in mutational input was explained by just two signatures that separate the wild-type and deficient tumours, signatures 3 and 4 separated mutations that occurred at LAPs and control sites (Supplemental Figure S6) . That is, we observe a shift in the types of mutations that occur at LAPs compared with control regions in both the deficient and wild-type tumours. In the breast cancer dataset, we do observe an unexpected excess of overlap between recurrently (> 2x) disrupted HMEC loops and GWAS regions associated with breast cancer: There were 40 such overlaps, whereas only 18.1 overlaps were, on average, observed in 5,000 circular permutations (p = 0.0002). This excess in overlap is notably larger than that observed for the background set of all HMEC loops and GWAS hits (225 observed overlaps and a mean of 143.6 expected overlaps, based on 5000 permutations; p = 0.001), suggesting a possible causal relationship between LAP disruption and the breast cancer phenotype. However, in common with previous studies (Kaiser and Semple 2017) , it is unclear to what extent this relationship is driven by the mutational biases that we have demonstrated at LAPs or selective processes in tumours. 
DISCUSSION
LAPs and recombination HSs are two seemingly unrelated features of the genomeone involved in chromatin organisation and the other in recombination during meiosis -but both classes of sites emerge as hotspots for DSBs. We have shown that LAPs and HSs often occur in the same genomic locations, which suggests that the same genomic regions that migrate to the chromosomal axis during meiosis, ultimately forming the points of breakage for DSB initiation (Baudat et al. 2013) , are also involved in chromatin organisation in the interphase nucleus of somatic cells.
Intriguingly, cohesin, which associates with CTCF at LAPs (Ong and Corces 2014; Tang et al. 2015) , is also enriched at the meiotic loop axis and plays a diverse role in chromosome pairing in both mitosis and meiosis (McNicoll et al. 2013) . A variety of factors, many related to chromatin structure, affect the propensity of LAPs to harbour SV breakpoints. PRDM9 also appears to be active in at least a subset of cancer cells (Feichtinger et al. 2012) and may contribute to DSB formation at LAPs, suggesting another possible link between LAPs and HSs. The association of LAPs with DSB formation appears to be at least partly attributable to the enrichment of active promoters and enhancers at LAPs, which is consistent with reports that promoters are inherently prone to DSBs, both in somatic cells (Lensing et al. 2016 ) and meiotic cells that lack PRDM9 (Brick et al. 2012 ). However, we also observe an excess of DSBs at
LAPs showing no overlap with promoter or enhancer states, and our modelling suggests that the presence of LAPs influences SV rates independently of features associated with these states. LAPs are also unusual with respect to replication timing, with LAPs replicating, on average, earlier than their surrounding regions -consistent with the dual roles of cohesin in stabilising chromatin loops and also initiating replication (Guillou et al. 2010) . Accordingly, chromatin looping may, to some extent, directly result from the initiation of replication, or, conversely, determine its starting position in the next cell cycle (Courbet et al. 2008) . Given the strong association between LAPs and DSB-prone regions, disruption of replication near such origins may be one way in which genome instability is introduced in cancer (Losada 2014). Notably, regions stably bound by DNA binding proteins such as CTCF seem to suffer high mutational loads due to replication errors (Reijns et al. 2015) .
LAPs are foci of DSB breakpoints and may provide the raw material for cancer evolution via structural variation, dependent on other factors, such as deficiencies in DNA repair pathways. The resulting SVs may have be subject to selection in cancer, though the majority are likely to be 'passenger' variants that drift toward fixation with little phenotypic consequences in their tissue of origin.
Accordingly, we observe a strong enrichment of somatic DSB formation at LAPs in the NHEK cell line, more modest elevations in SV breakpoints around LAPs in cancers, and limited evidence that the genes affected are those that experience selection in cancers. At the human population level, our results suggest that chromatin loops are predominantly inherited as a genetic unit, with recombination often confined to LAPs, and therefore tending to preserve regulatory haplotypes. Consistent with our results, recent studies have shown that LD blocks are enriched within topologically associating domains, i.e. recombination between enhancers and their target genes is reduced within domains (Liu et al. 2016) . Indeed, HSs themselves may primarily be a by-product of particular chromatin environments and other functional constraints, such as a lack of active transcription, which may interfere with the recombination process (McVicker and Green 2010).
We have used aggregate analysis across loop anchor points and cancer types, to show that a mutational bias towards breakage of chromatin loop anchors exists;
notably, it is more prominent in some cancer types than others and presumably depends on the general genome instability of the tumour type. The unusual somatic DNA breakage patterns near LAPs are likely to contribute to cancer evolution, reflected in higher SV breakpoint levels, and allowing novel promoter-enhancer interactions. The increase in breakage near LAPs is influenced by their specific chromatin environment and replication timing, DNA folding and accessibility to the repair machinery. Similar influences may underlie the surprising association of LAPs with meiotic recombination events.
METHODS
Datasets
Chromatin loops for cell lines representing all human germ layers (GM12878, HeLa, HMEC, HUVEC, IMR90, K562 and NHEK) were derived from unusually high resolution in situ Hi-C data, defining LAPs at a resolution of 1-5 Kb (GSE63525; (Rao et al. 2014) ). These loops are often conserved between cell lines, such that 55-75% of the loops detected in any given cell line were also found in the most deeply sequenced cell line (GM12878), and around 50% appear to be conserved across mammalian species (Rao et al. 2014) . The majority of loops are also associated with convergently orientated CTCF binding motifs at the putative LAPs, consistent with the known roles of CTCF in loop formation (Rao et al. 2014 ). On average, 17% of LAPs were only observed in one tissue (Supplemental Figure S7) (Table S2 ). We included all categories of structural variants that were listed in the ICGC files (i.e. insertions, deletions, inversions etc.), recording all breakpoint positions based on the coordinates of the SVs (i.e. a single SV has two breakpoint positions). SNV and breakpoint rates were intersected with the genomic coordinates of LAPs and HSs. Confidence intervals (as in Figure 1 ) were calculated based on the assumption that breakpoint and SNV rates are random processes and follow the Poisson distribution.
Germline de novo mutation rates were reported for a whole genome sequencing study of 283 Icelandic trios (Besenbacher et al. 2016 (Gel et al. 2016 ) was used to assess the significance of genome-wide overlap between LAPs and recombination HS, using 100,000 permutations. The 
